Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 13,583 shares at an average $35.46 ($481,621)
  2. 4 Open-market sale General Counsel sold 2,000 shares at an average $35.88 ($71,750)
  3. 4 Open-market sale Chief Scientific Officer sold 800 shares at an average $36.27 ($29,018)
  4. 4 Open-market sale Chief Business Officer sold 15,000 shares at an average $35.49 ($532,352)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Other disposition 10% owner disposed of 914,216 shares (other)
  11. 4 Exercise or conversion Chief Scientific Officer acquired 12,000 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Conversion 10% owner acquired 784,313 shares (conversion)
  14. 4 Conversion 10% owner acquired 1,176,470 shares (conversion)
  15. 4 Conversion 10% owner acquired 6,672,548 shares (conversion)
  16. 4 Conversion 10% owner acquired 6,672,548 shares (conversion)
  17. 4 Conversion 10% owner acquired 5,422,549 shares (conversion)
  18. 4 Insider Changes in Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 13 of 14 · 274 filings